D,L 3-(4-hydroxyphenyl) lactic acid hydrate | 1082680-72-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: D,L 3-(4-hydroxyphenyl) lactic acid hydrate
• 英文别名: 3-(4-hydroxyphenyl)-lactic acid hydrate；2-Hydroxy-3-(4-hydroxyphenyl)propanoic acid hydrate；2-hydroxy-3-(4-hydroxyphenyl)propanoic acid;hydrate
• CAS: 1082680-72-5
• 化学式: C₉H₁₀O₄*H₂O
• 分子量: 200.191
• InChiKey: BQVXPWODYNQPKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.44
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  78.8
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  D,L 3-(4-hydroxyphenyl) lactic acid hydrate 在 盐酸 作用下， 以 乙醇 为溶剂， 以0.54 g (2.57 mmol,94%)的产率得到3-(4-羟基苯基)乳酸乙酯
  参考文献：
  名称：

  Benzo-fused lactams that promote the release of growth hormone

  摘要：

  已披露了一些新型化合物，被确定为苯并咪唑内酰胺，可促进人类和动物体内生长激素的释放。这种特性可以用于促进食用动物的生长，使可食用肉制品的生产更加高效，在人类身上，可以增加那些缺乏正常分泌天然生长激素的人的身高。还披露了含有苯并咪唑内酰胺作为活性成分的促生长组合物。

  公开号：

  US05206235A1

文献信息

• Thyroid hormone receptor antagonists for cardiac and metabolic disorders ll
  申请人：——

  公开号：US20040220147A1

  公开（公告）日：2004-11-04

  This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subclinical hyperthyrodism and liver diseases.

  本发明涉及一种新型化合物，其为甲状腺受体配体，优选为拮抗剂，并且涉及使用这些化合物治疗心脏和代谢性疾病的方法，例如心律失常、甲状腺毒症、亚临床甲状腺功能亢进和肝脏疾病。
• Bioactive sensors
  申请人：Eichler Jutta

  公开号：US20050153357A1

  公开（公告）日：2005-07-14

  The present invention relates to sensors for the detection of molecular interactions between immobilized ligands and non-immobilized interaction partners (receptors). These surfaces use novel ligand-anchor conjugates which allow highly specific interaction with suitable interaction partners. Furthermore the invention relates to methods of providing the sensing surface and in particular methods of synthesising the ligand-anchor conjugates (LAC).

  本发明涉及用于检测固定配体和非固定相互作用伙伴（受体）之间分子相互作用的传感器。这些表面使用新型配体锚定物结合物，可以与适当的相互作用伙伴高度特异性地相互作用。此外，本发明涉及提供传感表面的方法，特别是合成配体锚定物结合物（LAC）的方法。
• Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
  申请人：Giannessi Fabio

  公开号：US20050032787A1

  公开（公告）日：2005-02-10

  Formula (I) compounds are described: Where the groups are as defined here below, and their use as medinies, particularly as serum glucose and serum lipid lowering agents. Said medicines are useful for the prophylaxis and treatment of diabetes, particularly type 2, and its complications, Syndrome X, the various forms of insulin resistance, and hyperlipidaemias, and present reduced side effects, and, particularly, reduced or no liver toxicity.

  描述了公式(I)化合物：其中各组如下所定义，并且它们的用途作为药物，特别是作为血清葡萄糖和血清脂质降低剂。所述药物对于预防和治疗糖尿病，特别是2型糖尿病及其并发症，综合征X，各种形式的胰岛素抵抗和高脂血症非常有用，并且具有减少的副作用，特别是减少或无肝毒性。
• Novel benzo-fused lactams that promote the release of growth hormone
  申请人：MERCK & CO. INC.

  公开号：EP0513974A1

  公开（公告）日：1992-11-19

  There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositiors containing such benzo-fused lactams as the active ingredient thereof are also disclosed.

  已公开的某些新型化合物被确定为苯并融合内酰胺，可促进人和动物体内生长激素的释放。这种特性可用于促进食用动物的生长，使可食用肉类产品的生产更有效率，也可用于提高那些缺乏正常天然生长激素分泌的人的身材。此外，还公开了以此类苯并内酰胺为活性成分的促进生长复合剂。
• Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds
  申请人：XEROX CORPORATION

  公开号：EP0667246A1

  公开（公告）日：1995-08-16

  A recording sheet which comprises a paper substrate and a material selected from the group consisting of monomeric amino acids, monomeric hydroxy acids, monomeric polycarboxyl compounds, and mixtures thereof. Another embodiment of the present invention is directed to a recording sheet which comprises a substrate and a material selected from the group consisting of monomeric amino acids, monomeric hydroxy acids, and mixtures thereof.

  一种记录纸，它包括纸基材和选自单体氨基酸、单体羟基酸、单体聚羧基化合物及其混合物组成的组的材料。本发明的另一个实施方案涉及一种记录纸，它包括基材和选自单体氨基酸、单体羟基酸及其混合物组成的组的材料。